MedTrace Logo

ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study.

NCT03252743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2019-02-26

No results posted yet for this study

Summary

This open trial aims to evaluate feasibility and preliminary effectiveness of an internet-delivered CBT-program for children and adolescents with functional gastrointestinal disorders when implemented in regular care.

Conditions

  • Functional Gastrointestinal Disorders
  • Irritable Bowel Syndrome
  • Dyspepsia
  • Functional Abdominal Pain

Interventions

BEHAVIORAL

Exposure-based internet-delivered CBT

The main target in treatment is exposure for abdominal symptoms by reducing avoidance and provoking symptoms. Participants are encouraged to gradually increase the difficulty by combining multiple challenges. The parents are taught how to reduce the risk for reinforcement of children's symptom behavior, and to support their child to complete the treatment. All treatment content is delivered over the internet, containing texts, videos, audio-files and examples. The modules are unlocked sequentially as participants worked their way through the treatment. Therapist support consists primarily of encouragement of any progress made in the treatment and support to find individual exercises.

Sponsors & Collaborators

Principal Investigators

  • Marianne Bonnert, PhD · Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2018-06-17
Completion
2018-12-18

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03252743 on ClinicalTrials.gov